Ensitrelvir
Ensitrelvir is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including XOCOVA. Available dosage form: tablet.
Drug Details
- Generic Name
- Ensitrelvir
- Brand Names
- XOCOVA
- Application Number
- NDA220442
- Sponsor
- Catalent Pharma Solutions, LLC
- NDC Codes
- 2
- Dosage Forms
- TABLET
- Routes
- ORAL
- Active Ingredients
- ENSITRELVIR
Indications and Usage
1 INDICATIONS AND USAGE XOCOVA is indicated for post-exposure prophylaxis of coronavirus disease 2019 (COVID-19) in adults and adolescents 12 years of age and older following contact with an individual who has COVID-19. XOCOVA, a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease (M pro : also referred to as 3CL pro or nsp5 protease) inhibitor, is indicated for post-exposure prophylaxis of coronavirus disease 2019 (COVID‑19) in adults and adolescents 12 years of age and older following contact with an individual who has COVID-19. ( 1 )